Organoids sales will expand through 2036, with intestinal organoid at 39.9% of product type demand and bio-banking at 35.8% of application sales in 2026. The market is estimated at USD 91.8 million in 2026, is projected to reach USD 349.5 million by 2036 and is forecast to record a 14.3% CAGR between 2026 and 2036.